http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02177897-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6bfdf49224a405be1f7b653c56ebad94
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
filingDate 1988-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fa384ad7c6d204692d9a5929f85ae6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a196212d6abf94d1f7383d1658677e33
publicationDate 1990-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H02177897-A
titleOfInvention Monoclonal antibody and immunoassay for biological substance using same
abstract NEW MATERIAL:A monoclonal antibody belonging to immunoglobulin G class 3, capable of specifically binding to at least sialyllacto N-fucopentaose II in the blood. n USE: Reagents for use in immunoassay for sialyllacto N-fucopentaose II, pancreatic carcinoma diagnostics. n PREPARATION: For example, Salmonella Minnesota bacteria incorporated with sialyllacto N-fucopentaose II is suspended into a phosphoric acid-buffered physiological saline solution, and the resulting suspension is injected into the abdomen of a BALB/C mouse to effect immunization. Three days after the final immunization, antibody-produced cells are collected from the spleen of the mouse, and fused with mouse myeloma cells followed by making a culture in a HAT medium into a hybridoma, which is then screened and put to cloning by e.g. critical dilution method followed by making a culture in the mouse abdomen and the resultant antibody is then separated from the ascites fluid, thus obtaining the objective monoclonal antibody. n COPYRIGHT: (C)1990,JPO&Japio
priorityDate 1988-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722

Total number of triples: 20.